Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that on December 1, 2025 (the “Grant Date”), Pulmonx ...
Picture a curtain lifting in an open window, not from force, but from invitation. That movement — is the essence of a “zephyr.” From poetry to ship names to high-fashion textiles, “zephyr” has drifted ...
WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ — PIH Health Whittier Hospital is now offering the Zephyr® Endobronchial Valve procedure, a breakthrough minimally invasive treatment option for patients ...
The MarketWatch News Department was not involved in the creation of this content. WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr(R) ...
REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback